Bright Minds Biosciences, Inc. (DRUG.CX)

111.25 +0.22 (+0.20%) CAD  |  CNSX  |  Mar 03, 11:41
More

Bright Minds Biosciences Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for DRUG.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Fennec Pharmaceuticals, Inc. Upgrade
Green Thumb Industries, Inc. Upgrade
Lowell Farms, Inc. --
Wesana Health Holdings, Inc. --
Sharp Therapeutics Corp. --

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade